Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations

Clinical and Experimental Allergy

Volumn 45, Issue 4, 2015, Pages 767-778

  Divekar, R D ^a   Samant, S ^b   Rank, M A ^c   Hagan, J ^a   Lal, D ^c   O'Brien, E K ^a   Kita, H ^a  

^a MAYO CLINIC   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Chronic rhinosinusitis; Exacerbation; GM CSF; Human rhinovirus; Nasal polyposis; VEGF

Indexed keywords

FRACTALKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; MAJOR BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; VASCULOTROPIN A;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE EXACERBATION; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; MALE; NETWORK LEARNING; NOSE POLYP; NOSE SECRETION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SNOT 22 SCORE; VIRUS DETECTION; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; CLUSTER ANALYSIS; COMPLICATION; DISEASE COURSE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NOSE MUCOSA; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RHINITIS; SINUSITIS; YOUNG ADULT;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; CLUSTER ANALYSIS; CYTOKINES; DISEASE PROGRESSION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; PROSPECTIVE STUDIES; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; RHINITIS; SINUSITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84925140777     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12463     Document Type: Article

References (29)

1. Meltzer EO, Hamilos DL, Hadley JA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114:155-212.
2. Bhattacharyya N. Contemporary assessment of the disease burden of sinusitis. Am J Rhinol Allergy 2009; 23:392-5.
3. Payne SC, Borish L, Steinke JW. Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol 2011; 128:710-20.
4. Rank MA, Hagan JB, Samant SA, Kita H. A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: data from a pilot study. Am J Rhinol Allergy 2013; 27:98-101.
5. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 2009; 34:447-54.
6. Morley AD, Sharp HR. A review of sinonasal outcome scoring systems - which is best? Clin Otolaryngol 2006; 31:103-9.
7. Dietz de Loos DA, Segboer CL, Gevorgyan A, Fokkens WJ. Disease-specific quality-of-life questionnaires in rhinitis and rhinosinusitis: review and evaluation. Curr Allergy Asthma Rep 2013; 13:162-70.
8. Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. In Third International AAAI Conference on Weblogs and Social Media (San Jose, CA: AAAI Publications, 2009), pp. 361-362.
9. Lopes CT, Franz M, Kazi F, Donaldson SL, Morris Q, Bader GD. Cytoscape Web: an interactive web-based network browser. Bioinformatics 2010; 26:2347-8.
10. Warde-Farley D, Donaldson SL, Comes O et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010; 38:W214-20.
11. Grotenboer NS, Ketelaar ME, Koppelman GH, Nawijn MC. Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J Allergy Clin Immunol 2013; 131:856-65.
12. O'Byrne PM, Gauvreau GM, Brannan JD. Provoked models of asthma: what have we learnt? Clin Exp Allergy 2009; 39:181-92.
13. Kistler A, Avila PC, Rouskin S et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 2007; 196:817-25.
14. Denlinger LC, Sorkness RL, Lee WM et al. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation. Am J Respir Crit Care Med 2011; 184:1007-14.
15. Peters AT, Kato A, Zhang N et al. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2010; 125:397-403.
16. Ramanathan M Jr, Lee WK, Spannhake EW, Lane AP. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol 2008; 22:115-21.
17. Van Zele T, Claeys S, Gevaert P et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61:1280-9.
18. Bradley DT, Kountakis SE. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis. Laryngoscope 2005; 115:684-6.
19. Kennedy JL, Hubbard MA, Huyett P, Patrie JT, Borish L, Payne SC. Sino-nasal outcome test (SNOT-22): a predictor of postsurgical improvement in patients with chronic sinusitis. Ann Allergy Asthma Immunol 2013; 111:246-51.
20. Farag AA, Deal AM, McKinney KA et al. Single-blind randomized controlled trial of surfactant vs hypertonic saline irrigation following endoscopic endonasal surgery. Int Forum Allergy Rhinol 2013; 3:276-80.
21. Snidvongs K, Pratt E, Chin D, Sacks R, Earls P, Harvey RJ. Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis. Int Forum Allergy Rhinol 2012; 2:415-21.
22. Videler WJ, Badia L, Harvey RJ et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy 2011; 66:1457-68.
23. Salib RJ, Talpallikar S, Uppal S, Nair SB. A prospective randomised single-blinded clinical trial comparing the efficacy and tolerability of the nasal douching products Sterimar and Sinus Rinse following functional endoscopic sinus surgery. Clin Otolaryngol 2013; 38:297-305.
24. Arron JR, Choy DF, Scheerens H, Matthews JG. Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthma. Ann Am Thorac Soc 2013; 10(Suppl):S206-13.
25. Coste A, Brugel L, Maître B et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 2000; 15:367-72.
26. Hamilos DL, Leung DY, Huston DP, Kamil A, Wood R, Hamid Q. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy 1998; 28:1145-52.
27. Allen JS, Eisma R, Leonard G, Kreutzer D. Interleukin-3 interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps. Am J Otolaryngol 1997; 18:239-46.
28. Van Crombruggen K, Zhang N, Gevaert P, Tomassen P, Bachert C. Pathogenesis of chronic rhinosinusitis: inflammation. J Allergy Clin Immunol 2011; 128:728-32.
29. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 2011; 186:4375-87.